Genetic matchmaking: new hope for lung cancer patients?
NCT ID NCT02664935
First seen May 07, 2026 · Last updated May 08, 2026 · Updated 1 time
Summary
This trial tested several targeted drugs in people with non-small cell lung cancer whose tumors had specific genetic changes. The goal was to see if these drugs could shrink tumors or delay cancer growth. Over 400 patients participated, and each received a drug matched to their tumor's genetic profile.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aberdeen Royal Infirmary
Aberdeen, United Kingdom
-
Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust
Cambridge, CB2 0QQ, United Kingdom
-
Beatson West of Scotland Cancer Centre
Glasgow, G12 0YN, United Kingdom
-
Belfast City Hospital, Belfast Health and Social Care Trust
Belfast, United Kingdom
-
Birmingham Heartlands Hospital, Heart of England NHS Foundation Trust
Birmingham, United Kingdom
-
Charing Cross Hospital, Imperial College Healthcare NHS Trust
London, United Kingdom
-
Churchill Hospital, Oxford University Hospitals NHS Foundation Trust
Oxford, United Kingdom
-
Clatterbridge Cancer Centre
Metropolitan Borough of Wirral, CH63 4JY, United Kingdom
-
Colchester General Hospital
Colchester, United Kingdom
-
Edinburgh Cancer Centre, Western General Hospital
Edinburgh, EH4 2XU, United Kingdom
-
Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust
London, United Kingdom
-
Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust
Leicester, United Kingdom
-
Maidstone Hospital
Maidstone, United Kingdom
-
Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust
Birmingham, B15 2GW, United Kingdom
-
Royal Devon and Exeter Hospital
Exeter, United Kingdom
-
Royal Marsden Hospital, The Royal Marsden NHS Foundation Trust
London, SW3 6JJ, United Kingdom
-
Sir Bobby Robson Cancer Trial Research Centre, The Newcastle upon Tyne Hospitals
Newcastle, NE7 7DN, United Kingdom
-
Southampton General Hospital, University Hospital Southampton NHS Foundation Trust
Southampton, SO16 6YD, United Kingdom
-
St Bartholomew's Hospital, Barts Health NHS Trust
London, United Kingdom
-
St. James' University Hospital, Leeds Teaching Hospital NHS Trust
Leeds, LS9 7TF, United Kingdom
-
The Christie Hospital, The Christie NHS Foundation Trust
Manchester, United Kingdom
-
University College Hospital, University College London Hospitals NHS Foundation Trust
London, United Kingdom
-
University Hospitals Bristol NHS Foundation Trust
Bristol, United Kingdom
-
Velindre Cancer Centre, Velindre NHS Trust
Cardiff, CF14 2TL, United Kingdom
-
Weston Park Hospital, Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield, United Kingdom
Conditions
Explore the condition pages connected to this study.